New Venture Funds Target Canadian Innovation
It is often said that start-up and emerging biotechnology companies require patient capital in order to execute on their business plans. Unfortunately, for Canadian biotechs they have had to be extremely patient waiting for capital.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter